tiprankstipranks
Trending News
More News >
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
US Market

Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Ratios

Compare
22 Followers

Shanghai Fosun Pharmaceutical (Group) Co Ratios

SFOSF's free cash flow for Q1 2025 was ¥0.48. For the 2025 fiscal year, SFOSF's free cash flow was decreased by ¥ and operating cash flow was ¥0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.92 1.00 1.06 1.04 1.01
Quick Ratio
0.73 0.78 0.85 0.85 0.80
Cash Ratio
0.36 0.41 0.49 0.35 0.40
Solvency Ratio
0.10 0.09 0.11 0.15 0.14
Operating Cash Flow Ratio
0.12 0.10 0.13 0.13 0.10
Short-Term Operating Cash Flow Coverage
0.24 0.23 0.35 0.42 0.33
Net Current Asset Value
¥ -23.04B¥ -23.06B¥ -17.78B¥ -14.49B¥ -12.62B
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.27 0.28 0.26 0.29
Debt-to-Equity Ratio
0.67 0.66 0.68 0.62 0.65
Debt-to-Capital Ratio
0.40 0.40 0.40 0.38 0.39
Long-Term Debt-to-Capital Ratio
0.18 0.23 0.22 0.19 0.19
Financial Leverage Ratio
2.49 2.48 2.40 2.38 2.26
Debt Service Coverage Ratio
0.39 0.45 0.56 0.75 0.70
Interest Coverage Ratio
2.96 2.50 8.61 7.68 5.36
Debt to Market Cap
0.82 0.68 0.43 0.26 0.21
Interest Debt Per Share
12.40 11.79 11.96 9.81 9.72
Net Debt to EBITDA
2.11 2.20 1.78 1.60 2.04
Profitability Margins
Gross Profit Margin
47.97%47.54%47.28%48.14%55.68%
EBIT Margin
13.64%11.09%12.60%17.60%18.34%
EBITDA Margin
20.95%18.25%17.92%22.30%22.74%
Operating Profit Margin
10.34%7.99%18.88%16.19%15.58%
Pretax Profit Margin
10.15%7.89%10.41%15.52%15.43%
Net Profit Margin
6.74%5.76%8.49%12.12%12.09%
Continuous Operations Profit Margin
8.55%6.99%8.98%12.76%13.00%
Net Income Per EBT
66.44%73.10%81.56%78.11%78.30%
EBT Per EBIT
98.21%98.70%55.14%95.88%99.08%
Return on Assets (ROA)
2.36%2.10%3.48%5.07%4.38%
Return on Equity (ROE)
5.86%5.22%8.37%12.07%9.90%
Return on Capital Employed (ROCE)
5.31%4.15%11.23%9.87%8.03%
Return on Invested Capital (ROIC)
3.62%3.11%8.34%7.09%5.96%
Return on Tangible Assets
3.18%2.80%4.61%6.71%5.77%
Earnings Yield
7.82%5.78%6.48%6.61%4.59%
Efficiency Ratios
Receivables Turnover
4.35 4.90 5.38 6.03 5.58
Payables Turnover
3.56 3.53 3.69 3.99 4.08
Inventory Turnover
2.94 2.88 3.37 3.70 2.60
Fixed Asset Turnover
1.75 1.86 2.74 2.94 2.33
Asset Turnover
0.35 0.36 0.41 0.42 0.36
Working Capital Turnover Ratio
-28.06 41.07 28.39 58.78 19.05
Cash Conversion Cycle
105.36 97.72 77.29 67.95 116.39
Days of Sales Outstanding
83.81 74.56 67.86 60.58 65.47
Days of Inventory Outstanding
124.00 126.69 108.42 98.74 140.30
Days of Payables Outstanding
102.46 103.53 98.99 91.37 89.38
Operating Cycle
207.82 201.25 176.29 159.32 205.77
Cash Flow Ratios
Operating Cash Flow Per Share
1.68 1.27 1.62 1.54 1.01
Free Cash Flow Per Share
0.02 -0.72 -0.64 -0.40 -0.73
CapEx Per Share
1.65 1.99 2.26 1.95 1.73
Free Cash Flow to Operating Cash Flow
0.01 -0.56 -0.40 -0.26 -0.72
Dividend Paid and CapEx Coverage Ratio
0.69 0.44 0.51 0.57 0.41
Capital Expenditure Coverage Ratio
1.02 0.64 0.72 0.79 0.58
Operating Cash Flow Coverage Ratio
0.14 0.11 0.14 0.16 0.11
Operating Cash Flow to Sales Ratio
0.11 0.08 0.10 0.10 0.09
Free Cash Flow Yield
0.19%-4.65%-2.90%-1.43%-2.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
12.79 17.31 15.44 15.12 21.80
Price-to-Sales (P/S) Ratio
0.86 1.00 1.31 1.83 2.63
Price-to-Book (P/B) Ratio
0.75 0.90 1.29 1.82 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
530.62 -21.48 -34.46 -69.84 -42.99
Price-to-Operating Cash Flow Ratio
7.92 12.10 13.66 18.11 30.95
Price-to-Earnings Growth (PEG) Ratio
0.76 -0.46 -0.68 0.51 2.18
Price-to-Fair Value
0.75 0.90 1.29 1.82 2.16
Enterprise Value Multiple
6.23 7.66 9.09 9.82 13.62
EV to EBITDA
6.23 7.66 9.09 9.82 13.62
EV to Sales
1.31 1.40 1.63 2.19 3.10
EV to Free Cash Flow
802.71 -30.11 -42.84 -83.45 -50.55
EV to Operating Cash Flow
11.98 16.96 16.98 21.64 36.40
Tangible Book Value Per Share
11.11 10.59 10.67 9.99 10.08
Shareholders’ Equity Per Share
17.68 17.04 17.09 15.33 14.44
Tax and Other Ratios
Effective Tax Rate
0.16 0.11 0.14 0.18 0.16
Revenue Per Share
15.37 15.44 16.85 15.26 11.83
Net Income Per Share
1.04 0.89 1.43 1.85 1.43
Tax Burden
0.66 0.73 0.82 0.78 0.78
Interest Burden
0.74 0.71 0.83 0.88 0.84
Research & Development to Revenue
0.09 0.11 0.10 0.10 0.09
SG&A to Revenue
0.03 0.11 0.02 0.02 0.03
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.27 1.43 1.07 0.79 0.65
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis